Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Martina Brueckmann

Rationale and Design of the EMPERIAL-Preserved and EMPERIAL-Reduced Trials of Empagliflozin in Patients With Chronic Heart Failure

European Journal of Heart Failure

Cardiovascular Medicine

English

Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline

European Journal of Heart Failure

Cardiovascular Medicine

English

Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial

European Journal of Heart Failure

Cardiovascular Medicine

English

Evaluation of the Effects of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality in Patients With Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR‐Preserved Trial

European Journal of Heart Failure

Cardiovascular Medicine

English

Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Phase 3, Single-Arm, Multicenter Study of Dabigatran Etexilate for Secondary Prevention of Venous Thromboembolism in Children: Rationale and Design

Research and Practice in Thrombosis and Haemostasis

English